Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Gains from Investment Securities (2016 - 2024)

Vycor Medical has reported Gains from Investment Securities over the past 10 years, most recently at -$662.0 for Q1 2024.

  • Quarterly Gains from Investment Securities fell 129.86% to -$662.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was -$120.0 through Jun 2024, up 96.79% year-over-year, with the annual reading at $680000.0 for FY2020, 2.86% down from the prior year.
  • Gains from Investment Securities was -$662.0 for Q1 2024 at Vycor Medical, down from $542.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $680000.0 in Q1 2020 and troughed at -$3198.0 in Q3 2022.
  • The 4-year median for Gains from Investment Securities is $542.0 (2023), against an average of $226593.1.
  • Year-over-year, Gains from Investment Securities surged 90687.72% in 2020 and then plummeted 129.86% in 2024.
  • A 4-year view of Gains from Investment Securities shows it stood at $680000.0 in 2020, then tumbled by 100.47% to -$3198.0 in 2022, then skyrocketed by 116.95% to $542.0 in 2023, then tumbled by 222.14% to -$662.0 in 2024.
  • Per Business Quant, the three most recent readings for VYCO's Gains from Investment Securities are -$662.0 (Q1 2024), $542.0 (Q3 2023), and -$254.0 (Q2 2023).